Instrument Inactif

Communiqués Cell Therapeutics Inc Nasdaq

Actions

US1509346029

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

26/06/23	Sobi finalise l'acquisition de CTI BioPharma pour 1,7 milliard de dollars	MT
26/06/23	En Direct des Marchés : TotalEnergies, Renault, Pernod Ricard, Sanofi, Euronext, Nvidia...

Communiqués

27/06/23	Sobi completes acquisition of CTI BioPharma Corp.	AQ
24/06/23	Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.	PR
06/06/23	CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC	BU
30/05/23	CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders	PR
16/05/23	CTI BioPharma: Q1 Earnings Snapshot	AQ
12/05/23	$1.7b acquisition to develop rare haematology therapy	AQ
11/05/23	CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC	BU
10/05/23	CTI BioPharma : TENDER AND SUPPORT AGREEMENT - Form 8-K	PU
10/05/23	CTI BIOPHARMA CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
10/05/23	Sobi to Acquire CTI BioPharma	PR
05/05/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
02/05/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
01/05/23	CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023	PR
12/04/23	CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023	PR
11/04/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
21/03/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
06/03/23	CTI BIOPHARMA CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
06/03/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
06/03/23	CTI BioPharma: Q4 Earnings Snapshot	AQ
01/03/23	CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference	PR
23/02/23	CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023	PR
08/02/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
02/02/23	CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023	PR
25/01/23	CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	PR
05/01/23	CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference	PR